WERKWIJZE VOOR DE BEREIDING VAN ANTHRACYCLINE GLYCOSIDE ANTIBIOTICA EN WERKWIJZE VOOR DE BEREIDING VAN EEN GENEESMIDDEL OP BASIS VAN DEZE ANTIBIOTICA

New antitumor agents named aclacinomycins A and B, which are anthracycline glycosides and inhibit the growth of various microorganisms e.g., Staphylococcus aureus, Micrococcus flavus, Corynebacterium bovis and inhibit the growth of animal tumors such as leukemia L1210 and P388 and lymphoma 6C3HED in...

Full description

Saved in:
Bibliographic Details
Main Authors TOSHIKAZU OKI TE KAMAKURA, HAMAO UMEZAWA, AKIRA TAKAMATSU TE YOKOHAMA, MASA HAMADA TE HOYA, TOMIO TAKEUCHI BEIDEN TE TOKIO, JAPAN
Format Patent
LanguageDutch
Published 16.12.1982
Edition3
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:New antitumor agents named aclacinomycins A and B, which are anthracycline glycosides and inhibit the growth of various microorganisms e.g., Staphylococcus aureus, Micrococcus flavus, Corynebacterium bovis and inhibit the growth of animal tumors such as leukemia L1210 and P388 and lymphoma 6C3HED in mice and hepatomas in rats are produced by the fermentation of a microorganism belonging to the genus Streptomyces which has been designated Streptomyces galilaeus (MA144-M1 and A.T.C.C. 31133); they are recovered from the broth by conventional methods for recovering antibiotics.
Bibliography:Application Number: NL19750008878